Valuation: Electromed, Inc.

Market Cap 337M 293M 273M 251M 473M 32.19B 480M 3.22B 1.26B 16.03B 1.27B 1.24B 53.74B P/E 2026 *
33.5x
P/E 2027 * 27.5x
Enterprise Value 337M 293M 273M 251M 473M 32.19B 480M 3.22B 1.26B 16.03B 1.27B 1.24B 53.74B EV / Sales 2026 *
4.58x
EV / Sales 2027 * 4.03x
Free-Float
82.82%
Yield 2026 *
-
Yield 2027 * -
1 day+1.14%
1 week+6.04%
1 month-7.58%
3 months+59.10%
6 months+36.36%
Current year+39.87%
1 week 38.4
Extreme 38.4
41.2
1 month 37.75
Extreme 37.75
47.4
Current year 23.01
Extreme 23.01
47.4
1 year 18.13
Extreme 18.13
47.4
3 years 8.8
Extreme 8.8
47.4
5 years 8.75
Extreme 8.75
47.4
10 years 3.38
Extreme 3.38
47.4
Manager TitleAgeSince
Chief Executive Officer 61 01/07/2023
Director of Finance/CFO 44 14/11/2022
Compliance Officer - 01/09/2023
Director TitleAgeSince
Chairman 69 01/07/2023
Director/Board Member 76 21/11/2014
Director/Board Member 57 15/08/2019
Date Insider Type Main position Quantity % Market Cap.
30/06/26 Tax

Chief Financial Officer

-674 0.0081%
01/12/25 Free

Director

3,000 0.0360%
01/12/25
Summers Value Partners LLC
OtherCompany 0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+1.14%+6.04%+124.66%+301.28% 337M
-0.43%+1.06%+24.03%+5.21% 212B
-0.61%+1.82%-1.07%-23.54% 137B
+0.10%+4.69%-26.86%+9.07% 125B
+1.59%+5.60%-55.67%-9.94% 69.46B
-0.98%+4.16%+8.50%+4.90% 49.56B
-0.91%+5.13%-20.61%-29.50% 47.2B
-0.25%-0.14%+21.91%+12.97% 39.08B
-0.79%+0.70%+29.97%+37.50% 37.05B
+0.00%+5.67%+116.67%+8.35% 30.97B
Average -0.11%+3.43%+22.15%+31.63% 74.79B
Weighted average by Cap. -0.24%+2.77%+3.75%-0.76%

Financials

2026 *2027 *
Net sales 73.6M 63.98M 59.55M 54.68M 103M 7.03B 105M 702M 275M 3.5B 276M 270M 11.73B 83.6M 72.67M 67.64M 62.1M 117M 7.98B 119M 797M 313M 3.97B 314M 307M 13.32B
Net income 10.53M 9.16M 8.52M 7.83M 14.78M 1.01B 15.01M 100M 39.43M 501M 39.56M 38.69M 1.68B 12.83M 11.16M 10.38M 9.53M 18M 1.23B 18.28M 122M 48.04M 610M 48.2M 47.14M 2.05B
Net Debt - -
Logo Electromed, Inc.
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Employees
179
Date Price Change Volume
31/07/26 $40.73 +1.14% 53,532
30/07/26 $40.27 +0.27% 54,009
29/07/26 $40.16 +1.72% 57,570
28/07/26 $39.48 -0.95% 91,155
27/07/26 $39.86 +3.78% 65,008
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
40.73USD
Average target price
40.33USD
Spread / Average Target
-0.97%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ELMD Stock